Watanabe Todd Franklin 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Watanabe Todd
DirectorSee Remarks
Transactions
- Gift
Common Stock
2025-06-10−997→ 913,116 total - Gift
Common Stock
2025-06-10−997→ 914,113 total - Gift
Common Stock
2025-06-10+997→ 25,410 total(indirect: By Trust) - Gift
Common Stock
2025-06-10+997→ 25,410 total(indirect: By Trust)
Holdings
- 57,358(indirect: By LLC)
Common Stock
- 124,956(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Includes 1,315 shares purchased under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on May 31, 2025.
- [F2]The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
- [F3]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 or for any other purposes.
- [F4]The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
- [F5]The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer.
- [F6]The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries.